Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Supriya Lifescience Ltd - 543434 - Board Meeting Intimation for Approval Of Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2023

 Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2023 ,inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2023 and to recommend dividend, if any, for the financial year ended March 31, 2023. This is further to inform you that with reference to our letter dated March 30, 2023 and in accordance with the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and the Company's Code of Conduct for Prevention of Insider Trading, the ''Trading Window' for dealing in the securities of the Company shall continue to remain closed till 48 hours after announcement of Audited Financial Results for the quarter and year ended March 31, 2023.
19-05-2023
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

 Pursuant to Regulation 32(6) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 read with Regulation 41(4) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, we are enclosing herewith Monitoring Agency Report issued by ICICI Bank Limited for the quarter ended March 31, 2023 in respect of utilization of proceeds of the of the fresh issue of the IPO of the Company.
15-05-2023
Bigul

Supriya Lifescience Ltd - 543434 - Regulation 44 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, And Scrutinizers Report In Respect Of Results Of E-Voting On The Resolutions Set Out Under Notice Of Postal Ballot Dated March 18, 2023

 Please find enclosed herewith Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Scrutinizer''s Report in respect of results of e-voting on the resolutions set out under Notice of Postal Ballot dated March 18, 2023.
24-04-2023
Bigul

Supriya Lifescience Ltd - 543434 - Scrutinizers Report In Respect Of Results Of E-Voting On The Resolutions Set Out Under Notice Of Postal Ballot Dated March 18, 2023

 Please find enclosed herewith Scrutinizer''s Report in respect of results of e-voting on the resolutions set out under Notice of Postal Ballot dated March 18, 2023 have been approved by the members with requisite majority.
22-04-2023
Bigul

Supriya Lifescience Ltd - 543434 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

 Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Supriya Lifescience Ltd 2 CIN NO. L51900MH2008PLC180452 3 Report filed for FY 2022-2023 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2022-2023, 2023-24 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2021-22, 2022-23 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Shweta SinghDesignation :-Company Secretary and Compliance Officer Name of the Chief Financial Officer :- Krishna Raghunathan Designation : -Chief Financial Officer Date: 21/04/2023
21-04-2023
Bigul

Supriya Lifescience Ltd - 543434 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanySupriya Lifescience Ltd 2CIN NO.L51900MH2008PLC180452 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 108574459.57 4Highest Credit Rating during the previous FY A 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Shweta Singh Designation: Company Secretary and Compliance Officer EmailId: cs@supriyalifescience.com Name of the Chief Financial Officer: Krishna Raghunathan Designation: Chief Financial Officer EmailId: cfo@supriyalifescience.com Date: 21/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
21-04-2023
Bigul

Supriya Lifescience Ltd - 543434 - Certificate Required Under Regulation 40(10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 With reference to the subject captioned above, please find enclosed herewith the certificate under Regulation 40(9) of the SEBI [Listing Obligations and Disclosure Requirements] (LODR) Regulations, 2015 for the year ended March 31, 2023 required to be submitted to the stock exchange as per the Regulation 40 (10) of the SEBI (LODR) Regulations, 2015.
18-04-2023
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited ('Company') will be interacting with Analyst/Institutional Investors on April 13, 2023 via in person meeting.
13-04-2023
Bigul

Supriya Lifescience Ltd - 543434 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find enclosed herewith a duly signed revised Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 received from Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company for the quarter ended March 31, 2023.
07-04-2023
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited ('Company') will be interacting with Analyst/Institutional Investors on April 10, 2023 via video conference.
07-04-2023
Next Page
Close

Let's Open Free Demat Account